Advertisements

Lopril H

Quick links to important sections

Lopril H

Advertisements

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Lopril H

Property Description
Active Ingredients Lisinopril, Hydrochlorothiazide
Form Oral Tablet
Pharmacological Class ACE Inhibitor with Thiazide Diuretic
General Purpose Management of High Blood Pressure
Origin Synthetic Chemical Compounds

Lopril H is a prescription-only fixed-dose combination medicine formulated as an oral tablet and is classified as an Antihypertensive Agent. Its generic name is Lisinopril/Hydrochlorothiazide, reflecting its composition of two distinct active compounds. This combination is also commercially available under other popular trade names, such as Prinzide and Zestoretic, indicating its established standing in the therapeutic field.

This medication belongs to the specialized pharmacological class known as ACE Inhibitors with Thiazide Diuretics. The two active ingredients include Lisinopril, a synthetic Angiotensin-Converting Enzyme (ACE) Inhibitor derived from a peptide, and Hydrochlorothiazide, a synthetic Thiazide Diuretic based on a sulfonamide structure. The use of these two agents is a recognized strategy in the initial and maintenance therapy for hypertension.

The General Purpose of This Dual-Component Therapy

The general therapeutic purpose of this dual-component therapy is the effective and sustained management of high blood pressure (hypertension), a typical use scenario for adults requiring comprehensive vascular and volume control. This is achieved through the complementary actions of the two active ingredients working together within the body.

This fixed-dose combination product influences the cardiovascular system via two critical mechanism principles: vessel relaxation provided by Lisinopril, and fluid reduction facilitated by Hydrochlorothiazide. This dual approach helps to lower the pressure exerted by the blood against the artery walls, which is the foundational aim of treating hypertension. The primary role of this combination is recognized for reducing the risk of serious complications associated with uncontrolled high blood pressure. This simultaneous action provides a more comprehensive means of achieving and maintaining target blood pressure levels.

Advertisements

What side effects are possible with Lopril H?

Possible Side Effects and Safety Information

The safety profile of Lopril H, a combination product, is defined by serious warnings, including a Boxed Warning for use during pregnancy, and a range of adverse reactions classified by frequency and affected body system.

Serious Safety Warnings

  • Fetal Toxicity: The medicine carries a Boxed Warning stating that use during the second and third trimesters of pregnancy can cause injury and death to the developing fetus. Official regulatory guidance requires discontinuation as soon as pregnancy is detected.
  • Angioedema: This is a rare, but serious, allergic reaction involving potentially life-threatening swelling of the face, tongue, glottis, and larynx, as well as intestinal swelling. It can occur at any time during treatment and mandates immediate and permanent discontinuation.
  • Systemic Risks: Serious risks documented include symptomatic Hypotension (excessively low blood pressure), Acute Renal Failure or worsening of impaired renal function, Hyperkalemia (increased blood potassium levels), and rare cases of Hepatic Failure or cholestatic jaundice.

Adverse Reactions

Adverse reactions documented in clinical trials and post-marketing surveillance are typically classified by their frequency.

Classification Examples of Reactions (System-Organ Classes)
Common Headache, dizziness, fatigue, persistent dry cough (respiratory), and diarrhea.
Uncommon / Rare Orthostatic effects, palpitations, rash, gout, and changes in blood components.

Population and Contextual Limitations

  • Contraindications: The medicine is restricted from use in patients with a history of Angioedema related to previous ACE inhibitor treatment, hereditary or idiopathic Angioedema, Anuria (due to the hydrochlorothiazide component), or hypersensitivity to sulfonamide-derived drugs.
  • Race: Official documents note that Black patients taking ACE inhibitors have been reported to have a higher incidence of angioedema. The antihypertensive effect may be less pronounced in this population compared to non-Black patients.
Advertisements

Overdose and Emergency Response

An overdose of the fixed-dose combination Lisinopril/Hydrochlorothiazide (Lopril H) is officially documented to present primarily as an exaggeration of its pharmacological effects, leading to profound physiological disturbances. The most critical signs include severe, prolonged hypotension (excessively low blood pressure), dehydration, and significant electrolyte imbalance. Manifestations documented in regulatory labeling may include symptoms such as lightheadedness, confusion, weakness, drowsiness, and vomiting. More severe manifestations, such as seizures, renal failure, and tachycardia (rapid or pounding heartbeat), have been reported in the context of overdosage.

Immediate medical attention is required when specific severe signs are present. Government guidelines explicitly state that emergency services must be called if the individual has collapsed, experienced a seizure, has trouble breathing, or cannot be awakened. Upon recognition of a suspected overdosage, regulatory instructions mandate the immediate discontinuation of therapy and close patient observation.

Treatment for overdosage is defined as symptomatic and supportive. No specific antidote is known for this combination product. Management protocols described in official documents focus on correction of dehydration, electrolyte imbalance, and hypotension using established procedures. Close observation and frequent monitoring of serum electrolytes and creatinine are required in the overdose setting.

Advertisements

Therapeutic Uses of Lopril H

Lopril H is a combination medication indicated for the management of hypertension, which is also known as high blood pressure.

Controlling elevated blood pressure is a significant component of cardiovascular risk management. Maintaining blood pressure within a target range may assist in reducing the potential for adverse health outcomes, including stroke and myocardial infarction.

This medication is typically reserved for adult patients whose blood pressure is not adequately maintained with single-drug therapy. It provides a means to support the achievement of blood pressure goals when prescribed as part of a comprehensive treatment plan.


Quick Facts

  • Therapeutic Domain: Assists in the management of high blood pressure (hypertension).
  • Primary Use: Contributes to the reduction of elevated blood pressure levels.
  • Treatment Context: May be considered when a single medication is insufficient to attain blood pressure goals.
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Lopril H?

The population eligibility for using Lopril H (Lisinopril/Hydrochlorothiazide) is strictly defined by regulatory authorities and centers on age, reproductive status, and pre-existing medical conditions.


Contraindicated Populations (Must Not Use)

Category Prohibition Criteria
Allergy/History Known hypersensitivity to the drug, any ACE inhibitor, or any sulfonamide-derived drug; history of angioedema related to any ACE inhibitor or hereditary/idiopathic angioedema [Source 1, 3].
Organ Function Anuria, severe renal impairment (creatinine clearance less than 30 mL/min), or severe hepatic impairment [Source 1, 2].
Reproductive Status Pregnancy, particularly the second and third trimesters; the drug must be discontinued immediately upon detection of pregnancy [Source 1].
Concomitant Drugs Use with Neprilysin inhibitors (e.g., sacubitril/valsartan) or with Aliskiren in patients who also have Diabetes Mellitus or renal impairment [Source 1, 4].

Eligibility and Restricted Use

Lopril H is indicated for use only in adult patients [Source 2]. Use in the pediatric population is not recommended, as safety and efficacy have not been established [Source 3]. The medicine is not recommended for use while breastfeeding [Source 1]. Patients with moderate renal impairment (creatinine clearance 30–80 mL/min) or with conditions like aortic stenosis may only use the fixed-dose combination with caution and under restricted conditions, often following titration of the individual components [Source 3].

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Lopril H (Lisinopril/Hydrochlorothiazide) is defined by documented regulatory restrictions concerning combinations that may alter drug exposure or produce additive pharmacodynamic effects.

Contraindicated Combinations and Timing Rules

Co-administration with Sacubitril/Valsartan is a formally contraindicated combination due to the risk of angioedema; a 36-hour separation window is mandatory between doses. Additionally, the drug is contraindicated with Aliskiren in patients diagnosed with Diabetes Mellitus or Renal Impairment (GFR less than 60 mL/min/1.73 m^2).

Pharmacodynamic and Exposure Interactions

The combination with Potassium-sparing diuretics (e.g., Spironolactone) or Potassium supplements increases the risk of Hyperkalemia (high potassium) due to additive effects. Co-administration with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) may result in a loss of antihypertensive efficacy and heighten the risk of renal function deterioration. The clearance of Lithium is reduced when taken with Lopril H, increasing its plasma concentration and risk of toxicity. Alcohol consumption may intensify the risk of orthostatic hypotension.

Population-Specific Interaction Notes

Pharmacokinetic data indicates that Elderly Patients may exhibit increased plasma exposure (AUC) to both lisinopril (approx. 120% increase) and hydrochlorothiazide (approx. 80% increase) compared to younger patient populations.

Advertisements

Mechanism of Action

Lopril H, a combination product, modulates systemic physiology through two distinct mechanisms involving its active components, lisinopril and hydrochlorothiazide.

Lisinopril acts as a competitive inhibitor of the angiotensin-converting enzyme (ACE), a peptidyl dipeptidase. ACE catalyzes the conversion of the inactive decapeptide angiotensin I to the potent vasoconstrictor octapeptide angiotensin II within the plasma and tissue. By inhibiting this conversion, lisinopril reduces the systemic concentration of angiotensin II, a molecular signal that normally induces vasoconstriction and stimulates the adrenal cortex to secrete aldosterone. The subsequent decrease in angiotensin II leads to reduced peripheral arterial resistance via vasodilation, and decreased aldosterone secretion results in diminished renal tubular reabsorption of sodium and water in the distal nephron. Furthermore, ACE is identical to kininase II, an enzyme that degrades the vasodilator bradykinin. Inhibition of ACE may lead to an accumulation of bradykinin, contributing to the systemic vasodilation.

Hydrochlorothiazide functions as an inhibitor of the sodium-chloride symporter (NCC) located on the apical membrane of the distal convoluted tubule cells in the kidney. This molecular interaction blocks the reabsorption of approximately 5-10% of filtered sodium and chloride. The resulting intracellular pathway modification leads to increased urinary excretion of sodium, chloride, and water, a process termed diuresis. The loss of intravascular fluid volume, a downstream cascade, contributes to a net decrease in systemic peripheral vascular resistance.

Advertisements

Dosage and Administration Information

Official Administration Guidelines for Lopril H

Lopril H (Lisinopril/Hydrochlorothiazide) is a fixed-dose combination prescribed as an oral tablet and is used according to specific, standardized protocols.


Administration Scope Detail
Route of administration Oral (swallowed whole).
Dosing schedule The standard initial dose is typically 10 mg/12.5 mg or 20 mg/12.5 mg per day. The maximum recommended dose is 80 mg Lisinopril/50 mg Hydrochlorothiazide per day.
Timing in relation to meals May be taken with or without food.
Frequency and Timing The entire daily dose is taken once daily at approximately the same time each day.
Age-group administration rules The fixed-dose combination is not approved for use in children; its safety and effectiveness have not been established in the pediatric population. No specific adjustment is required for older adults.
Missed-dose rules If a dose is missed, it should be skipped, and the next dose should be taken at the usual time. Double doses should not be taken.
Special procedural conditions The combination is generally initiated only after titration of the individual components. Diuretic therapy must be discontinued for 2 to 3 days prior to starting Lopril H to help minimize a sharp drop in blood pressure. The fixed-dose combination is not recommended for patients with severe renal impairment (Creatinine Clearance <30 mL/min).

Resulting Procedural Structure

The protocol defines the use of Lopril H as a once-daily oral regimen intended for long-term administration. Instructions require that patients who were previously on a separate diuretic should generally stop that diuretic for several days prior to initiation. Dosing is individualized based on the patient's response to the separate components before the combination tablet is administered, and subsequent dosage adjustments are performed every two to three weeks up to the maximum labeled daily dose.

Advertisements

Recent Clinical Evidence

Lopril H: Recent Clinical Evidence

Lopril H is a fixed-dose combination therapy containing the ACE inhibitor lisinopril and the thiazide diuretic hydrochlorothiazide. Clinical trials have consistently demonstrated that this combination provides superior blood pressure reduction compared to either lisinopril or hydrochlorothiazide used alone (monotherapy).


Efficacy in Hypertension and Organ Protection

Clinical evidence shows that the additive effect of the two drugs effectively controls blood pressure in a significant majority of patients with mild, moderate, and severe essential hypertension. Studies have reported success rates (reduction to target blood pressure, e.g., leq 140/90 mmHg) in over 80% of patients.

Beyond blood pressure control, the lisinopril component, as an ACE inhibitor, contributes to cardiovascular risk reduction. In patients with hypertension and left ventricular hypertrophy (LVH), a condition linked to increased cardiovascular morbidity, clinical trials show that treatment with the lisinopril-hydrochlorothiazide combination leads to a regression of the left ventricular mass index in over 50% of patients. This is considered an important goal of antihypertensive therapy.


Safety and Tolerability Profile

The fixed-dose combination is generally well-tolerated. The complementary mechanism of action helps to mitigate some of the potential adverse metabolic effects of hydrochlorothiazide alone, such as its tendency to lower potassium levels. Lisinopril’s potassium-retaining effect helps to stabilize serum potassium levels, resulting in a modest mean decrease when the two are combined, which still requires monitoring.

Commonly reported side effects in clinical trials include dizziness, headache, cough (associated with ACE inhibitors), and fatigue. Withdrawals from treatment due to adverse effects are relatively infrequent. The incidence and nature of adverse effects have been shown to be similar across various patient populations, including the elderly.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Lopril H (FAQ)

Q: How quickly does Lopril H start to lower blood pressure?

Official information indicates that the blood pressure lowering effect from the lisinopril component typically begins within one hour of taking the medicine. The strongest effect on blood pressure usually occurs about six hours after the dose.


Q: Does Lopril H work right away or take several weeks?

While an initial blood pressure reduction starts within hours, the full benefit of Lopril H may not be reached immediately. Studies indicate that reaching the full blood pressure-lowering effect may require consistent, daily administration for several weeks.


Q: What happens if I stop taking Lopril H suddenly?

Regulatory guidance notes that sudden, unsupervised discontinuation of this medicine is generally not recommended. Abruptly stopping blood pressure medication can lead to a rapid increase in blood pressure, known as rebound hypertension, which may raise the risk of serious events such as a heart attack or stroke.


Q: Can I take Lopril H with my multivitamin?

Official guidance specifically warns that patients should avoid potassium supplements or salt substitutes that contain potassium, as these can interact with Lopril H. For all other over-the-counter medicines, vitamins, or supplements, the official patient information highlights the importance of consulting a healthcare provider before use.


Q: Will taking Lopril H mean I have to limit salt in my diet?

Lopril H is frequently used alongside other management strategies, which may include lifestyle adjustments. This medicine is often used in combination with a low-salt (low-sodium) diet for optimal blood pressure management. A discussion with your care team is typically required to determine necessary dietary restrictions, including the use of salt substitutes.


Q: Can Lopril H affect my blood sugar levels if I have diabetes?

Yes, official patient safety information notes that Lopril H may potentially affect blood sugar levels. If you have diabetes, the official guidance indicates that regular blood sugar monitoring is usually necessary, and dose adjustments for diabetes medication may be considered by your doctor.


Q: Why do official documents warn about the risk of skin cancer with the diuretic part of this medicine?

Official warnings exist regarding a dose-dependent increased risk of non-melanoma skin cancer associated with the hydrochlorothiazide component (the diuretic). This risk is seen with increasing cumulative exposure, especially over long periods of use. Official patient guidance recommends limiting sun exposure and performing regular skin checks.


Q: Is Lopril H associated with any effect on weight?

Weight change is not specifically listed as a common or uncommon side effect in the official prescribing information. Clinical studies that examined the combination did not find a significant association between treatment and changes in weight or Body Mass Index (BMI).


Q: Does Lopril H impact sexual function or libido?

Changes in sexual ability or libido are occasionally mentioned as an uncommon or rare side effect in patient materials. Concerns about sexual function should be discussed with a healthcare provider.


Q: Will I need to take Lopril H for the rest of my life?

Lopril H is prescribed to manage high blood pressure, which is generally considered a chronic, long-term condition that cannot be cured. Because of the nature of the condition, long-term, daily administration of blood pressure medication is typical for many patients to help control their blood pressure.


Q: Can Lopril H affect my vision or cause eye problems?

Yes, regulatory documents contain a specific warning that the diuretic component can rarely cause an idiosyncratic reaction leading to acute transient myopia (sudden nearsightedness) and acute angle-closure glaucoma. Symptoms like decreased vision, eye pain, or seeing halos are identified as serious events that warrant immediate medical evaluation.


Q: Is there a risk of fever or sore throat while on Lopril H?

Fever and sore throat are mentioned in official patient materials as signs that require immediate contact with a healthcare provider. These symptoms can sometimes indicate a more serious underlying issue, such as changes in blood cell counts (e.g., a low white blood cell count).


Q: How is Lopril H different from other blood pressure medicines?

Lopril H is a fixed-dose combination of two different classes of antihypertensive agents: an ACE inhibitor (lisinopril) and a thiazide diuretic (hydrochlorothiazide). This dual mechanism allows it to control blood pressure through both vessel relaxation and fluid reduction, which is a different approach than using a single agent alone.


Q: Is it possible for Lopril H to cause low potassium levels?

The diuretic component (hydrochlorothiazide) tends to lower potassium, while the ACE inhibitor (lisinopril) tends to retain it, resulting in a stabilizing effect on potassium levels. However, low potassium (hypokalemia) is still a possibility that requires monitoring, as indicated by regulatory and clinical sources.


Q: What are the long-term effects of taking Lopril H?

In addition to controlling blood pressure, the lisinopril component is linked to cardiovascular risk reduction and the regression of certain heart changes, according to clinical evidence. The medicine is generally well-tolerated during long-term maintenance, though monitoring is required for long-term safety concerns like changes in electrolytes and kidney function.


Q: What kind of monitoring (blood tests) is usually required while on Lopril H?

Because this medicine affects fluid and electrolyte balance, periodic monitoring is required. Official guidance indicates that your doctor will likely request routine blood tests to check your kidney function and electrolyte levels, especially potassium, to ensure they remain stable during therapy.


Q: Can Lopril H cause a feeling of a 'lump in the throat'?

A feeling of a 'lump in the throat' may be a sign of angioedema, a rare but serious side effect involving swelling that can affect the larynx (voice box) and glottis. The symptoms of angioedema are considered serious events that warrant immediate medical evaluation.


Q: How can I tell the difference between a minor side effect and a serious one with Lopril H?

Official safety warnings clearly distinguish between common, less serious side effects like headache or fatigue, and Serious Safety Warnings. Serious reactions like chest pain, fainting, difficulty breathing, or swelling of the face/throat (angioedema) are identified as medical emergencies.


Q: Are there any dietary restrictions other than salt to consider with Lopril H?

Yes, in addition to any salt limitations advised by your doctor, official documents caution against taking potassium supplements or salt substitutes containing potassium. Furthermore, consumption of alcohol is a topic typically discussed with a doctor, as it may increase the risk of low blood pressure when standing (orthostatic hypotension).


Q: Does Lopril H cause sun sensitivity or skin reactions?

The diuretic component of this medicine, hydrochlorothiazide, has been associated with photosensitivity, meaning it can cause the skin to be more sensitive to the sun. Regulatory warnings recommend limiting sun exposure, wearing protective clothing, and using sunscreen.


Q: Why do I need to be cautious about getting dehydrated while taking Lopril H?

Lopril H contains a diuretic that causes your kidneys to increase the excretion of water and salt, which is how it lowers blood pressure. This fluid loss means there is a necessary caution regarding the risk of dehydration, especially during hot weather, heavy exercise, or periods of illness where you lose a lot of fluids.

Advertisements

How should Lopril H be stored and disposed of?

Official Storage and Disposal Instructions

The storage and disposal requirements for Lisinopril/Hydrochlorothiazide tablets (Lopril H) are strictly defined by regulatory labeling to maintain product stability and ensure public safety.

Requirement Official Condition
Temperature Store at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F).
Protection Keep the container tightly closed and away from moisture, damp areas, and excess heat.
Container Store in the container in which it came.
Child Safety Mandatory to store the medication out of the reach of children.
Disposal Do not keep outdated medicine; discard unused product according to local regulations or via an established drug take-back program.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Lopril H found in:

A-Z Index: